Pricing Log in Create free account

Spruce Biosciences, Inc. (SPRB) vs Protara Therapeutics, Inc. (TARA)

Spruce Biosciences, Inc. and Protara Therapeutics, Inc. are both Biotechnology companies. Spruce Biosciences, Inc. and Protara Therapeutics, Inc. are of similar size ($135.9M and $133.8M). Across the 11 metrics below, Protara Therapeutics, Inc. leads on 6 and Spruce Biosciences, Inc. on 5.

Valuation

Metric SPRB TARA Biotechnology median
P/E n/m n/m 10.60
P/S 23.04 n/m 9.40
P/B 1.35 0.87 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.02 0.66
EV/Sales 4.88 n/m 9.02
Earnings yield (88.60%) (58.70%) (32.88%)
Free cash flow yield (37.80%) (47.40%) (23.13%)

Profitability

Metric SPRB TARA Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (105.98%) (45.80%) (51.96%)
Return on assets (82.38%) (42.05%) (46.06%)
Return on invested capital 0.00% (255.06%) 0.00%

Growth

Metric SPRB TARA Biotechnology median
Revenue growth (TTM) (51.32%) — 6.76%
EPS growth (last fiscal year) 47.59% 38.25% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SPRB TARA Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 9.23 10.97 4.97
Net debt to EBITDA 1.34 2.38 1.01

Dividend

Metric SPRB TARA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SPRB TARA Biotechnology median
Market cap 133.79m 135.92m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack